Pattern of cancer/testis antigen expression in lung cancer patients

Kim,Yeong-Dae; Park,Hae-Rim; Song,Myung-Ha; Shin,Dong-Hoon; Lee,Chang-Hun; Lee,Min-Ki; Lee,Sang-Yull

doi:10.3892/ijmm.2012.896

Pattern of cancer/testis antigen expression in lung cancer patients

Authors:
- Yeong-Dae Kim
- Hae-Rim Park
- Myung-Ha Song
- Dong-Hoon Shin
- Chang-Hun Lee
- Min-Ki Lee
- Sang-Yull Lee
View Affiliations

Affiliations: Department of Thoracic Surgery, Pusan National University Hospital, Seo-gu, Busan 602-739, Republic of Korea, Department of Biochemistry, School of Medicine, Pusan National University, Beomeo-ri, Mulgeum-eup, Yangsan 626-770, Republic of Korea
Published online on: January 24, 2012 https://doi.org/10.3892/ijmm.2012.896
Pages: 656-662

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer/testis (CT) antigens represent promising targets for immunotherapy. We investigated the composite expression of 13 CT antigens by RT-PCR in 79 lung cancer tissues and by immunohistochemistry in 22 lung cancer tissues. In the 79 lung cancer tissues, MAGE-3 (42%) was expressed most frequently and followed by NY-SAR-35 (33%), NY-ESO-1 (30%), MAGE-1 (27%), CT-7 (20%), MAGE-4 (19%), LAGE-1 (16%), and MAGE-10 (14%). Twenty-one tissues did not express any of the CT antigens tested, 58 (73%) expressed at least one, 36 (46%) co-expressed two, 24 (30%) co-expressed three, 17 (22%) co-expressed four, 14 (18%) co-expressed five, 8 (10%) co-expressed six, 4 (6%) co-expressed seven and 2 tissues expressed 9 of the 13 examined CT antigens. Expression of CT antigens was significantly associated with age (P<0.001), smoking history (P=0.009), and gender (P=0.001) of patients, whereas no correlation was found between the expression of CT antigens and other clinical factors, such as pT status, pN status, tumor stage, and histology history. The present results show that CT antigens are potential candidates in lung cancer patients for polyvalent immunotherapy.

View Figures

View References

1	DM ParkinF BrayJ FerlayP PisaniGlobal cancer statistics, 2002CA Cancer J Clin5574108200510.3322/canjclin.55.2.74
2	LJ OldCancer vaccines 2003: opening addressCancer Immun3Suppl 2S12003
3	MJ ScanlanAJ SimpsonLJ OldThe cancer/testis genes: review, standardization, and commentaryCancer Immun41200414738373
4	PG CoulieV BrichardA Van PelT WolfelJ SchneiderC TraversariS MatteiE De PlaenC LurquinJP SzikoraA new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasJ Exp Med1803542199410.1084/jem.180.1.358006593
5	S LabrecqueN NaorD ThomsonG MatlashewskiAnalysis of the anti-p53 antibody response in cancer patientsCancer Res533468347119938339249
6	ML DisisE CalenoffG McLaughlinAE MurphyW ChenB GronerM JeschkeN LydonE McGlynnRB LivingstonExistent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancerCancer Res54162019947505195
7	T BoonPG CoulieB Van den EyndeTumor antigens recognized by T cellsImmunol Today18267268199710.1016/S0167-5699(97)80020-59190110
8	YT ChenAO GureS TsangE StockertE JagerA KnuthLJ OldIdentification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line libraryProc Natl Acad Sci USA9569196923199810.1073/pnas.95.12.69199618514
9	AJ SimpsonOL CaballeroA JungbluthYT ChenLJ OldCancer/testis antigens, gametogenesis and cancerNat Rev Cancer5615625200510.1038/nrc166916034368
10	RB ParmigianiF BettoniMD VibranovskiMH LopesWK MartinsIW CunhaFA SoaresAJ SimpsonSJ de SouzaAA CamargoCharacterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patientsProc Natl Acad Sci USA1031806618071200610.1073/pnas.060885310317114284
11	OL CaballeroYT ChenCancer/testis (CT) antigens: potential targets for immunotherapyCancer Sci10020142021200910.1111/j.1349-7006.2009.01303.x19719775
12	P van der BruggenC TraversariP ChomezC LurquinE De PlaenB Van den EyndeA KnuthT BoonA gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanomaScience254164316471991
13	P BoelC WildmannML SensiR BrasseurJC RenauldP CoulieT BoonP van der BruggenBAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytesImmunity2167175199510.1016/S1074-7613(95)80053-07895173
14	B Van den EyndeO PeetersO De BackerB GauglerS LucasT BoonA new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaJ Exp Med1826896981995
15	O TureciU SahinI SchobertM KoslowskiH ScmittHJ SchildF StennerG SeitzHG RammenseeM PfreundschuhThe SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40Cancer Res564766477219968840996
16	YT ChenMJ ScanlanU SahinO TureciAO GureS TsangB WilliamsonE StockertM PfreundschuhLJ OldA testicular antigen aberrantly expressed in human cancers detected by autologous antibody screeningProc Natl Acad Sci USA9419141918199710.1073/pnas.94.5.19149050879
17	O TureciU SahinC ZwickM KoslowskiG SeitzM PfreundschuhIdentification of a meiosis-specific protein as a member of the class of cancer/testis antigensProc Natl Acad Sci USA9552115216199810.1073/pnas.95.9.52119560255
18	SY LeeY ObataM YoshidaE StockertB WilliamsonAA JungbluthYT ChenLJ OldMJ ScanlanImmunomic analysis of human sarcomaProc Natl Acad Sci USA10026512656200310.1073/pnas.043797210012601173
19	SY LeeB WilliamsonOL CaballeroYT ChenMJ ScanlanG RitterCV JongeneelAJ SimpsonLJ OldIdentification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancerCancer Immun413200415546177
20	U SahinO TureciH SchmittB CochloviusT JohannesR SchmitsF StennerG LuoI SchobertM PfreundschuhHuman neoplasms elicit multiple specific immune responses in the autologous hostProc Natl Acad Sci USA921181011813199510.1073/pnas.92.25.118108524854
21	K TajimaY ObataH TamakiM YoshidaYT ChenMJ ScanlanLJ OldH KuwanoT TakahashiT MitsudomiExpression of cancer/testis (CT) antigens in lung cancerLung Cancer422333200310.1016/S0169-5002(03)00244-714512184
22	JR TsaiIW ChongYH ChenMJ YangCC SheuHC ChangJJ HwangJY HungSR LinDifferential expression profile of MAGE family in non-small-cell lung cancerLung Cancer56185192200710.1016/j.lungcan.2006.12.00417208331
23	LH SobinP HermanekRV HutterTNM classification of malignant tumors. A comparison between the new (1987) and the old editionsCancer6123102314198810.1002/1097-0142(19880601)61:11%3C2310::AID-CNCR2820611127%3E3.0.CO;2-X3284634
24	SH KimS LeeCH LeeMK LeeYD KimDH ShinKU ChoiJY KimY Park doMY SolExpression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltrationLung187401411200910.1007/s00408-009-9181-319795170
25	P WeynantsB LetheF BrasseurM MarchandT BoonExpression of mage genes by non-small-cell lung carcinomasInt J Cancer56826829199410.1002/ijc.29105606128119772
26	S LucasC De SmetKC ArdenCS ViarsB LetheC LurquinT BoonIdentification of a new MAGE gene with tumor-specific expression by representational difference analysisCancer Res5874375219989485030
27	C FischerF GudatP StulzC NoppenC SchaeferP ZajacM TrutmannT KocherM ZuberF HarderHigh expression of MAGE-3 protein in squamous-cell lung carcinomaInt J Cancer7111191121199710.1002/(SICI)1097-0215(19970611)71:6%3C1119::AID-IJC34%3E3.0.CO;2-59185722
28	MJ ScanlanNK AltorkiAO GureB WilliamsonA JungbluthYT ChenLJ OldExpression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9Cancer Lett150155164200010.1016/S0304-3835(99)00385-710704737
29	D RimoldiV Rubio-GodoyV DutoitD LienardS SalviP GuillaumeD SpeiserE StockertG SpagnoliC ServisEfficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanomaJ Immunol16572537261200010.4049/jimmunol.165.12.725311120859
30	F van RheeSM SzmaniaF ZhanSK GuptaM PomtreeP LinRB BatchuA MorenoG SpagnoliJ ShaughnessyNY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responsesBlood10539393944200515671442
31	B LetheS LucasL MichauxC De SmetD GodelaineA SerranoE De PlaenT BoonLAGE-1, a new gene with tumor specificityInt J Cancer76903908199810.1002/(SICI)1097-0215(19980610)76:6%3C903::AID-IJC22%3E3.0.CO;2-19626360
32	JH ParkMH SongCH LeeMK LeeYM ParkL OldSY LeeExpression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylationBiotechnol Lett3310851091201110.1007/s10529-011-0559-y21318630
33	A MischoB KubuschokK ErtanKD PreussB RomeikeE RegitzC SchormannD de BruijnA WadleF NeumannProspective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancerInt J Cancer118696703200610.1002/ijc.2135216094643